Role of Ultrasound in Diagnosis of Placenta Previa and MAP

Evaluation of Role of Ultrasound TA,TV,TP in Diagnosis of Placenta Previa and MAP(Morbidly Adherent Placenta )

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03416296

Enrollment

Registered

2018-01-31

Start date

2018-03-15

Completion date

2019-12-20

Last updated

2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbidly Adherent Placenta

Brief summary

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

Detailed description

The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 43 Years

Healthy volunteers

Yes

Inclusion criteria

* pregnant ladies with previous cesarean sections * GA above 30 weeks

Exclusion criteria

* Primigravida patients * GA below 30 weeks

Design outcomes

Primary

Measure	Time frame
number of participants who will be diagnosed to have normal placenta or placenta previa or morbidly adherent placenta by US	within 6 weeks

Countries

Egypt

Outcome results